Fulgent Genetics Inc.

Industry

  • Biotechnology
    • Gene Therapy, Cell Therapy
    • Drug Discovery Technologies
      • Genomics-Proteomics
  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
  • Laboratory Testing Services

Other Names/Subsidiaries

  • Fulgent Pharma Holdings, Inc.
  • Fulgent Therapeutics LLC
  • Fulgent Investment Development Limited
  • Inform Diagnostics
  • Shenzhen Mingrui Consulting Co., Ltd.
  • Fulgent Genetics Canada Inc.
  • Shenzhen Fujin Gene Technology Co., Ltd.
See more in Biomedtracker

Latest on Fulgent Genetics Inc.

Scrip

Xian Under Lockdown, mRNA Vaccines Remain Elusive In China

 
• By Brian Yang

Xi'an, a city of 13 million people in Northeastern China, is under strict lockdown amid a regional COVID-19 outbreak, the worst in the country since January 2020 when similarly-sized Wuhan was placed

Medtech Insight

Q3 IPO Volume On The Up

 
• By Catherine Longworth

IPO volume rose with seven initial public offerings filed and completed in the third quarter of 2016, sparking hopes for an IPO rebound in 2016. According to deals tracked by Strategic Transactions ,

In Vivo

Deals Shaping the Medical Industry, October 2016

 
• By Steven Muntner, Beth Allan, Maureen Riordan, Deanna Kamienski, and Amanda Micklus

IN VITRO DIAGNOSTICS Mergers & Acquisitions Alere Inc. TechLab Inc. Pharos Capital Group has taken a controlling interest in TechLab Inc. from Alere Inc. and TechLab's founders Dr. Tracy Wilki

In Vivo

Device/Diagnostics Quarterly Deal Statistics, Q4 2016

 
• By Amanda Micklus and Maureen Riordan

Device Transactions Device companies aggregated $2.4 billion in financing for the fourth quarter of 2016, representing an 18% decrease from Q3's $3 billion. Despite the decline, Q4 put up the second-s